Welcome to The Visible Embryo

Home- - -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- News Alerts -Contact

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than ' million visitors each month.


WHO International Clinical Trials Registry Platform
The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!



Home

History

Bibliography

Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Alerts Archive

Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

Return To Top Of Page
Pregnancy Timeline by SemestersFemale Reproductive SystemFertilizationThe Appearance of SomitesFirst TrimesterSecond TrimesterThird TrimesterFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterDevelopmental Timeline
Click weeks 0 - 40 and follow fetal growth
Search artcles published since 2007

September 11, 2012--------News Archive Return to: News Alerts


The sugar called 2-fucosyllactose, or 2FL, is a human milk oligosaccharide (HMO)
which has not been added to any infant formula because the HMO is incredibly
expensive to produce.

WHO Child Growth Charts

       

Metabolic Engineer Synthesizes Key Breast Milk Sugar

A microbial engineer has synthesized a sugar in human milk that is thought to protect babies from pathogens

The sugar called 2-fucosyllactose, or 2FL, is a human milk oligosaccharide (HMO) which has not been added to any infant formula because the HMO is incredibly expensive to produce.

"We know these oligosaccharides play a vital role in developing a breast-fed baby's gut microbiota and in strengthening their immunity. And 2FL is the most abundant HMO in breast milk," said Michael Miller, a University of Illinois professor of food microbiology.

In order to learn more about the HMO's function, Miller would like to do research with 2FL and newborn piglets, an excellent animal model for the human infant. Unfortunately, 1 milligram of 2FL costs $100, therefore, a single study would require $1 million for the HMO ingredient alone.

However, Yong-Su Jin, a departmental colleague and professor in the University of Illinois Institute for Genomic Biology, believed he could synthesize the breast milk oligosaccharide using an engineered strain of E. coli. Additionally, a postdoctoral researcher in Jin's laboratory had done similar work in Korea. So, combining their experienced staff and expertise, they were able to engineer an HMO that can be produced very cheaply and quickly, making it possible to produce 2FL in the lab, allowing Miller's piglet research.

"E. coli makes a starting material for 2FL as part of its normal metabolism, and that suggested to us that it was possible to use E. coli to produce 2FL," Jin said.

"We increased the production of the starting material (GDP-fucose), by getting E. coli to overexpress the pre-existing biosynthetic pathway. Then we had to transfer GDP-fucose to lactose. We solved that problem by engineering a gene into another organism," Jin explained.

They developed an E. coli mutant that can assimilate lactose. "Because the engineered mutant cannot use the lactose for its own growth, it instead uses lactose to make great quantities of 2FL, the HMO that many researchers want to study," said Jin.

Miller will soon begin a study of the role of 2FL in infant nutrition to assess whether it should be added to infant formula. Miller: "We can also use this technique to synthesize and study the hundreds of other HMOs in human milk."

The research potentially has other useful potential unrelated to infant nutrition.

Jin and Miller believe that their work has military applications. Jin: "Adding 2FL to the food of soldiers on deployment could keep them out of sick bay. More than half of all soldiers in the field are incapacitated at some point with diarrheal illness caused by Campylobacter jejuni."

A second use might be a reduction in the number of Campylobacter infections that originate in raw or undercooked poultry.

Miller: "If chickens consumed poultry feed containing 2FL, pathogens would bind to this oligosaccharide instead of the mucosal lining of the bird's intestine and be eliminated well before the chicken arrived at your supermarket."

"Whole cell biosynthesis of a functional oligosaccharide, 2'-fucosyllactose, using engineered Escherichia coli" was published in Microbial Cell Factories and is available online at http://www.microbialcellfactories.com/content/11/1/48.

Co-authors with Jin and Miller are Won Heong Lee, Panchalee Pathanibul, and Josh Quarterman of the U of I, Nam Soo Han of Chungbuk National University in Korea, and Jung-Hyun Jo and Jin-Ho Seo of Seoul National University in Korea. Jin and Lee are affiliated with the U of I's Institute for Genomic Biology, and Lee is also affiliated with Seoul National University.

Original article: http://research.aces.illinois.edu/content/metabolic-engineer-synthesizes-key-breast-milk-ingredient-makes-research-possible